New Drugs

The following items were added to the drug file for September 2017.

Drug Name Form Strength Qty
Apohealth Anti-Inflammatory Pain Relief Tab-EC 25mg 20
Apohealth Anti-Inflammatory Pain Relief Tab-EC 25mg 30
Bimatoprost Sandoz Eye-Drp 0.3mg/mL, 3mL 1
Dilaudid HP Inj 50mg/1mL 5
Mepreze Tab-EC 20mg 14
Momasone Oint 0.1%, 15g 1
Momasone Oint 0.1%, 15g 2
Momasone Oint 0.1%, 15g 4
Momasone Oint 0.1%, 15g 6
Momasone Oint 0.1%, 15g 8
Momasone Oint 0.1%, 15g 10
Neocate Junior # Pwdr 400g 8
Raloxifene Amneal Tab 60mg 28
Somavert # Vl 10mg, 30 1
Somavert # Vl 15mg, 30 1
Somavert # Vl 20mg, 1 4
Somavert # Vl 20mg, 30 1
Stelara ^ Vl 45mg/0.5mL 2
Stelara # Vl 130mg/26mL 4
Ursofalk Tab 250mg 100
Xolair ^ Syrn-P/F 150mg/1mL 2
Zydelig ^ Tab 150mg 60

# Item has more than one PBS listing
^ Additional PBS listing(s) for an existing drug

Private to PBS/RPBS

The following items were transferred from Private to PBS.

Drug Name Form Strength Qty
Nevirapine XR Apotex # Tab 400mg 60
Valganciclovir Juno # Tab 450mg 120
Zydelig # Tab 100mg 60

New and Revised CMIs

The following CMIs are new or revised for September 2017.

CMI Name Status
Alcaine New
APO-Fluoxetine New
APO-Pregabalin New
Arcoxia Revised
Azarga New
Azopt New
Bexsero Revised
Blincyto Revised
Bosentan Mylan Revised
Bosentan Sandoz New
BrinzoQuin New
Brufen Tablets Revised
Coveram Revised
Coversyl Revised
Coversyl Plus Revised
Darzalex New
Doryx Revised
DuoTrav New
EES Granules New
Eloctate Revised
Elonva Revised
Enalapril HCT Sandoz Revised
Esomeprazole Apotex Revised
Evotaz Revised
Femoston 1/10 Revised
Femoston 2/10 Revised
Femoston-Conti Revised
Ferriprox Oral Solution 25/250 New
Ferriprox Oral Solution 50/500 New
Ferriprox Tablets 500 New
Flarex New
Flucon New
Gopten Revised
Idaprex Revised
Idaprex Combi Revised
Isopto Carpine New
Kalma Revised
Kivexa Revised
Kombiglyze XR Revised
Mayne Pharma Doxycycline Revised
Monopril Revised
Nucala Revised
Ocrevus New
Ofev Revised
Olmesartan HCT-MYL Revised
Olmesartan/Amlodipine-MYL Revised
Olmetec Plus Revised
Onglyza Revised
Opdivo Revised
OxyNorm Injection Revised
OxyNorm Liquid Revised
Prexum Revised
Prexum Combi Revised
Protos Revised
Rapifen Revised
Reaptan Revised
Retrovir Revised
Reyataz Revised
Rhinocort Hayfever Revised *
Risperidone Sandoz Revised
Seroquel Revised
Seroquel XR Revised
Sevikar Revised
Sevikar HCT Revised
Sifrol Revised
Sifrol ER Revised
Somavert New
Staphylex Revised
Symbicort Turbuhaler Revised
Tecentriq New
Trajenta Revised
Trajentamet Revised
Tramedo Revised
Tramedo SR Revised
Trizivir Revised
Vallergan Revised
Zestril Revised
Ziagen Oral Solution Revised
Ziagen Tablets Revised
Zinbryta Revised
Zomig Revised

* Transferred from AstraZeneca to Johnson & Johnson

Withdrawn CMIs

The following CMIs are withdrawn as of September 2017.

CMI Name Status
Antistax Withdrawn
Bisolvon Chesty Forte Liquid On-The-Go Sachets Withdrawn
Bisolvon Chesty Natural Kids Oral Liquid Withdrawn
Bisolvon Pholcodine Dry Forte Oral Liquid Withdrawn
Buscopan Ampoules Withdrawn
Buscopan Tablets Withdrawn
Codapane Forte 500/30 Withdrawn
Dulcolax SP Drops Withdrawn
Dulcolax Suppositories Withdrawn
Dulcolax Tablets Withdrawn
EES Withdrawn
Finalgon Withdrawn
Xanopan Withdrawn